Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO® (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.
- generic_name
- ibalizumab
- product_names
- ibalizumab
- ndc
- 62064-122, 62064-122-01, 62064-122-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en